IBDEI14G ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,18197,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18197,1,3,0)
;;=3^Hypertension Secondary to Oth Renal Disorders
;;^UTILITY(U,$J,358.3,18197,1,4,0)
;;=4^I15.1
;;^UTILITY(U,$J,358.3,18197,2)
;;=^5007072
;;^UTILITY(U,$J,358.3,18198,0)
;;=I15.2^^61^806^2
;;^UTILITY(U,$J,358.3,18198,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18198,1,3,0)
;;=3^Hypertension Secondary to Endocrine Disorders
;;^UTILITY(U,$J,358.3,18198,1,4,0)
;;=4^I15.2
;;^UTILITY(U,$J,358.3,18198,2)
;;=^5007073
;;^UTILITY(U,$J,358.3,18199,0)
;;=I15.8^^61^806^16
;;^UTILITY(U,$J,358.3,18199,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18199,1,3,0)
;;=3^Secondary Hypertension,Oth
;;^UTILITY(U,$J,358.3,18199,1,4,0)
;;=4^I15.8
;;^UTILITY(U,$J,358.3,18199,2)
;;=^5007074
;;^UTILITY(U,$J,358.3,18200,0)
;;=I15.9^^61^806^17
;;^UTILITY(U,$J,358.3,18200,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18200,1,3,0)
;;=3^Secondary Hypertension,Unspec
;;^UTILITY(U,$J,358.3,18200,1,4,0)
;;=4^I15.9
;;^UTILITY(U,$J,358.3,18200,2)
;;=^5007075
;;^UTILITY(U,$J,358.3,18201,0)
;;=I16.0^^61^806^14
;;^UTILITY(U,$J,358.3,18201,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18201,1,3,0)
;;=3^Hypertensive Urgency
;;^UTILITY(U,$J,358.3,18201,1,4,0)
;;=4^I16.0
;;^UTILITY(U,$J,358.3,18201,2)
;;=^8133013
;;^UTILITY(U,$J,358.3,18202,0)
;;=I16.1^^61^806^7
;;^UTILITY(U,$J,358.3,18202,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18202,1,3,0)
;;=3^Hypertensive Emergency
;;^UTILITY(U,$J,358.3,18202,1,4,0)
;;=4^I16.1
;;^UTILITY(U,$J,358.3,18202,2)
;;=^8204721
;;^UTILITY(U,$J,358.3,18203,0)
;;=I16.9^^61^806^6
;;^UTILITY(U,$J,358.3,18203,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18203,1,3,0)
;;=3^Hypertensive Crisis,Unspec
;;^UTILITY(U,$J,358.3,18203,1,4,0)
;;=4^I16.9
;;^UTILITY(U,$J,358.3,18203,2)
;;=^5138600
;;^UTILITY(U,$J,358.3,18204,0)
;;=A07.0^^61^807^5
;;^UTILITY(U,$J,358.3,18204,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18204,1,3,0)
;;=3^Balantidiasis
;;^UTILITY(U,$J,358.3,18204,1,4,0)
;;=4^A07.0
;;^UTILITY(U,$J,358.3,18204,2)
;;=^12533
;;^UTILITY(U,$J,358.3,18205,0)
;;=A07.1^^61^807^9
;;^UTILITY(U,$J,358.3,18205,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18205,1,3,0)
;;=3^Giardiasis [lambliasis]
;;^UTILITY(U,$J,358.3,18205,1,4,0)
;;=4^A07.1
;;^UTILITY(U,$J,358.3,18205,2)
;;=^5000049
;;^UTILITY(U,$J,358.3,18206,0)
;;=A07.2^^61^807^7
;;^UTILITY(U,$J,358.3,18206,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18206,1,3,0)
;;=3^Cryptosporidiosis
;;^UTILITY(U,$J,358.3,18206,1,4,0)
;;=4^A07.2
;;^UTILITY(U,$J,358.3,18206,2)
;;=^29629
;;^UTILITY(U,$J,358.3,18207,0)
;;=A07.3^^61^807^12
;;^UTILITY(U,$J,358.3,18207,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18207,1,3,0)
;;=3^Isosporiasis
;;^UTILITY(U,$J,358.3,18207,1,4,0)
;;=4^A07.3
;;^UTILITY(U,$J,358.3,18207,2)
;;=^5000050
;;^UTILITY(U,$J,358.3,18208,0)
;;=A07.4^^61^807^8
;;^UTILITY(U,$J,358.3,18208,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18208,1,3,0)
;;=3^Cyclosporiasis
;;^UTILITY(U,$J,358.3,18208,1,4,0)
;;=4^A07.4
;;^UTILITY(U,$J,358.3,18208,2)
;;=^321973
;;^UTILITY(U,$J,358.3,18209,0)
;;=A07.8^^61^807^14
;;^UTILITY(U,$J,358.3,18209,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18209,1,3,0)
;;=3^Protozoal Intestinal Diseases,Oth Spec
;;^UTILITY(U,$J,358.3,18209,1,4,0)
;;=4^A07.8
;;^UTILITY(U,$J,358.3,18209,2)
;;=^265972
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI14G 3781 printed Apr 09, 2024@21:50:39 Page 2
IBDEI14G ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,18197,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,18197,1,3,0)
+4 ;;=3^Hypertension Secondary to Oth Renal Disorders
+5 ;;^UTILITY(U,$J,358.3,18197,1,4,0)
+6 ;;=4^I15.1
+7 ;;^UTILITY(U,$J,358.3,18197,2)
+8 ;;=^5007072
+9 ;;^UTILITY(U,$J,358.3,18198,0)
+10 ;;=I15.2^^61^806^2
+11 ;;^UTILITY(U,$J,358.3,18198,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,18198,1,3,0)
+14 ;;=3^Hypertension Secondary to Endocrine Disorders
+15 ;;^UTILITY(U,$J,358.3,18198,1,4,0)
+16 ;;=4^I15.2
+17 ;;^UTILITY(U,$J,358.3,18198,2)
+18 ;;=^5007073
+19 ;;^UTILITY(U,$J,358.3,18199,0)
+20 ;;=I15.8^^61^806^16
+21 ;;^UTILITY(U,$J,358.3,18199,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,18199,1,3,0)
+24 ;;=3^Secondary Hypertension,Oth
+25 ;;^UTILITY(U,$J,358.3,18199,1,4,0)
+26 ;;=4^I15.8
+27 ;;^UTILITY(U,$J,358.3,18199,2)
+28 ;;=^5007074
+29 ;;^UTILITY(U,$J,358.3,18200,0)
+30 ;;=I15.9^^61^806^17
+31 ;;^UTILITY(U,$J,358.3,18200,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,18200,1,3,0)
+34 ;;=3^Secondary Hypertension,Unspec
+35 ;;^UTILITY(U,$J,358.3,18200,1,4,0)
+36 ;;=4^I15.9
+37 ;;^UTILITY(U,$J,358.3,18200,2)
+38 ;;=^5007075
+39 ;;^UTILITY(U,$J,358.3,18201,0)
+40 ;;=I16.0^^61^806^14
+41 ;;^UTILITY(U,$J,358.3,18201,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,18201,1,3,0)
+44 ;;=3^Hypertensive Urgency
+45 ;;^UTILITY(U,$J,358.3,18201,1,4,0)
+46 ;;=4^I16.0
+47 ;;^UTILITY(U,$J,358.3,18201,2)
+48 ;;=^8133013
+49 ;;^UTILITY(U,$J,358.3,18202,0)
+50 ;;=I16.1^^61^806^7
+51 ;;^UTILITY(U,$J,358.3,18202,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,18202,1,3,0)
+54 ;;=3^Hypertensive Emergency
+55 ;;^UTILITY(U,$J,358.3,18202,1,4,0)
+56 ;;=4^I16.1
+57 ;;^UTILITY(U,$J,358.3,18202,2)
+58 ;;=^8204721
+59 ;;^UTILITY(U,$J,358.3,18203,0)
+60 ;;=I16.9^^61^806^6
+61 ;;^UTILITY(U,$J,358.3,18203,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,18203,1,3,0)
+64 ;;=3^Hypertensive Crisis,Unspec
+65 ;;^UTILITY(U,$J,358.3,18203,1,4,0)
+66 ;;=4^I16.9
+67 ;;^UTILITY(U,$J,358.3,18203,2)
+68 ;;=^5138600
+69 ;;^UTILITY(U,$J,358.3,18204,0)
+70 ;;=A07.0^^61^807^5
+71 ;;^UTILITY(U,$J,358.3,18204,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,18204,1,3,0)
+74 ;;=3^Balantidiasis
+75 ;;^UTILITY(U,$J,358.3,18204,1,4,0)
+76 ;;=4^A07.0
+77 ;;^UTILITY(U,$J,358.3,18204,2)
+78 ;;=^12533
+79 ;;^UTILITY(U,$J,358.3,18205,0)
+80 ;;=A07.1^^61^807^9
+81 ;;^UTILITY(U,$J,358.3,18205,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,18205,1,3,0)
+84 ;;=3^Giardiasis [lambliasis]
+85 ;;^UTILITY(U,$J,358.3,18205,1,4,0)
+86 ;;=4^A07.1
+87 ;;^UTILITY(U,$J,358.3,18205,2)
+88 ;;=^5000049
+89 ;;^UTILITY(U,$J,358.3,18206,0)
+90 ;;=A07.2^^61^807^7
+91 ;;^UTILITY(U,$J,358.3,18206,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,18206,1,3,0)
+94 ;;=3^Cryptosporidiosis
+95 ;;^UTILITY(U,$J,358.3,18206,1,4,0)
+96 ;;=4^A07.2
+97 ;;^UTILITY(U,$J,358.3,18206,2)
+98 ;;=^29629
+99 ;;^UTILITY(U,$J,358.3,18207,0)
+100 ;;=A07.3^^61^807^12
+101 ;;^UTILITY(U,$J,358.3,18207,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,18207,1,3,0)
+104 ;;=3^Isosporiasis
+105 ;;^UTILITY(U,$J,358.3,18207,1,4,0)
+106 ;;=4^A07.3
+107 ;;^UTILITY(U,$J,358.3,18207,2)
+108 ;;=^5000050
+109 ;;^UTILITY(U,$J,358.3,18208,0)
+110 ;;=A07.4^^61^807^8
+111 ;;^UTILITY(U,$J,358.3,18208,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,18208,1,3,0)
+114 ;;=3^Cyclosporiasis
+115 ;;^UTILITY(U,$J,358.3,18208,1,4,0)
+116 ;;=4^A07.4
+117 ;;^UTILITY(U,$J,358.3,18208,2)
+118 ;;=^321973
+119 ;;^UTILITY(U,$J,358.3,18209,0)
+120 ;;=A07.8^^61^807^14
+121 ;;^UTILITY(U,$J,358.3,18209,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,18209,1,3,0)
+124 ;;=3^Protozoal Intestinal Diseases,Oth Spec
+125 ;;^UTILITY(U,$J,358.3,18209,1,4,0)
+126 ;;=4^A07.8
+127 ;;^UTILITY(U,$J,358.3,18209,2)
+128 ;;=^265972
